Keyphrases
Graft-versus-host Disease (GvHD)
100%
Immune Reconstitution
100%
Allogeneic Transplantation
100%
Umbilical Cord Blood
100%
Mortality Risk
100%
Blood Recipients
83%
Unrelated Donor
66%
Natural Killer Cells
33%
CD4+ T Cells
33%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
CD4+
33%
CD8+
33%
Cell number
33%
Donor-recipient Matching
33%
Treatment-related Mortality
33%
Infection Surveillance
16%
T Cells
16%
Bacterial Infection
16%
B Cells
16%
Memory T Cells
16%
Infection Risk
16%
T Cell Subsets
16%
T Regulatory
16%
Effector Memory
16%
Viral Infection
16%
Reduced-intensity Conditioning
16%
Peripheral Blood
16%
Risk Treatment
16%
Donor Type
16%
CD3+
16%
Prolonged Infection
16%
Regulatory T
16%
Infection Prophylaxis
16%
Acceleration Strategy
16%
Adult Recipients
16%
Immunology and Microbiology
Umbilical Cord Blood
100%
Immune Reconstitution
100%
Chronic Graft Versus Host Disease
100%
Allograft
100%
Natural Killer Cell
33%
T-Helper Cell
33%
Cell Transplantation
33%
CD4
33%
CD8
33%
Hematopoietic Cell
33%
B Cell
16%
Viral Disease
16%
T Cell Subset
16%
Conditioning
16%
T Cell
16%
CD3 Antigen
16%